Search Results

Antheia and Olon Group announced an ongoing partnership to leverage Olon’s vast fermentation infrastructure to manufacture Antheia’s early products.

OLON Group announces the start of construction of a new facility at its Rodano site which will be entirely dedicated to managing and producing Ultra-Potent compounds, used for example as payloads and payload-linkers for ADCs, one of the most promising emerging cancer therapies, which combines the effective killing power of small molecule cytotoxins and the highly specific targeting ability of monoclonal antibodies.

Olon Group and the Politecnico di Milano, Department of Chemistry, Materials and Chemical Engineering “Giulio Natta,” jointly announce an innovative public-private partnership agreement for a research project on the advanced study of polymorphism and the characterization of the solid state of the molecules of active ingredients.